Patents by Inventor Andrew C NYBORG

Andrew C NYBORG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Uricase sequences and methods of treatment
    Patent number: 11098289
    Abstract: Described are improved uricase sequences having beneficial effects and methods of treating patients suffering from hyperuricemia.
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: August 24, 2021
    Assignee: MedImmune, LLC
    Inventors: Manuel Baca, Andrew C. Nyborg
  • URICASE SEQUENCES AND METHODS OF TREATMENT
    Publication number: 20210254024
    Abstract: Described are improved uricase sequences having beneficial effects and methods of treating patients suffering from hyperuricemia.
    Type: Application
    Filed: November 18, 2020
    Publication date: August 19, 2021
    Inventors: Manuel BACA, Andrew C. NYBORG
  • Uricase sequences and methods of treatment
    Patent number: 10883087
    Abstract: Described are improved uricase sequences having beneficial effects and methods of treating patients suffering from hyperuricemia.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: January 5, 2021
    Assignee: MedImmune, LLC
    Inventors: Manuel Baca, Andrew C. Nyborg
  • URICASE SEQUENCES AND METHODS OF TREATMENT
    Publication number: 20190048327
    Abstract: Described are improved uricase sequences having beneficial effects and methods of treating patients suffering from hyperuricemia.
    Type: Application
    Filed: October 23, 2018
    Publication date: February 14, 2019
    Inventors: Manuel BACA, Andrew C. NYBORG
  • Improved Uricase Sequences and Methods of Treatment
    Publication number: 20180258406
    Abstract: Described are improved uricase sequences having beneficial effects and methods of treating patients suffering from hyperuricemia.
    Type: Application
    Filed: May 13, 2016
    Publication date: September 13, 2018
    Inventors: Manuel Baca, Andrew C. NYBORG
  • METHODS FOR TREATING CLOSTRIDIUM DIFFICILE INFECTION AND ASSOCIATED DISEASE
    Publication number: 20180085458
    Abstract: The invention features methods for treating Clostridium difficile infection (CDI), C. difficile associated disease, and symptoms thereof, featuring the use of antibodies having enhanced half-life that specifically bind C. difficile toxin A and/or toxin B. In one aspect, the invention provides a method of treating a C. difficile infection or C. difficile-associated disease in a subject, the method involving administering to the subject a combination of an anti-C. difficile toxin A antibody and an anti-C. difficile toxin B antibody having an alteration that increases the half-life of one or both antibodies relative to anti-C. difficile toxin A and B antibodies lacking the alteration. In one aspect, the invention features a composition comprising an equimolar mixture of an anti-toxin A antibody and an anti-toxin B antibody. The invention provides kits for treating a C. difficile infection or symptoms thereof.
    Type: Application
    Filed: April 14, 2016
    Publication date: March 29, 2018
    Inventors: Andrew C NYBORG, Paul WARRENER, Godfrey RAINEY